Jane Street’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.78M | Buy |
127,122
+10,646
| +9% | +$149K | ﹤0.01% | 2241 |
|
2025
Q1 | $1.82M | Buy |
116,476
+11,035
| +10% | +$173K | ﹤0.01% | 2356 |
|
2024
Q4 | $1.47M | Sell |
105,441
-5,631
| -5% | -$78.4K | ﹤0.01% | 2484 |
|
2024
Q3 | $1.03M | Sell |
111,072
-39,033
| -26% | -$363K | ﹤0.01% | 3351 |
|
2024
Q2 | $1.4M | Sell |
150,105
-63,431
| -30% | -$590K | ﹤0.01% | 3206 |
|
2024
Q1 | $2.12M | Buy |
213,536
+52,935
| +33% | +$525K | ﹤0.01% | 2254 |
|
2023
Q4 | $519K | Buy |
160,601
+37,576
| +31% | +$121K | ﹤0.01% | 4063 |
|
2023
Q3 | $653K | Sell |
123,025
-29,802
| -20% | -$158K | ﹤0.01% | 3340 |
|
2023
Q2 | $1.46M | Buy |
152,827
+126,572
| +482% | +$1.21M | ﹤0.01% | 2716 |
|
2023
Q1 | $289K | Buy |
+26,255
| New | +$289K | ﹤0.01% | 4294 |
|
2022
Q4 | – | Sell |
-19,081
| Closed | -$365K | – | 5482 |
|
2022
Q3 | $365K | Buy |
+19,081
| New | +$365K | ﹤0.01% | 3973 |
|
2022
Q2 | – | Sell |
-14,398
| Closed | -$277K | – | 5501 |
|
2022
Q1 | $277K | Buy |
+14,398
| New | +$277K | ﹤0.01% | 4386 |
|
2020
Q4 | – | Sell |
-10,959
| Closed | -$321K | – | 3843 |
|
2020
Q3 | $321K | Buy |
+10,959
| New | +$321K | ﹤0.01% | 2805 |
|